18 results with keyword: 'primary renal cell carcinoma metastases renal carcinoma cancer'
RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; PRCC : papil- lary renal cell carcinoma; ChRCC : chromophobe renal cell carcinoma; TCGA : The Cancer Genome
N/A
[24] detected that metastases demonstrated higher expression of programmed death ligand 1 (PD-L1) that connects with the costimulatory receptor on T cells and promotes inactivation
N/A
The most common primary tumours to give rise to pancreatic metastases are lung cancer, breast cancer, renal cell carcinoma, malignant melanoma, carcinoma of gastrointestinal origin
N/A
RCT: renal cell tumour; RCC: renal cell carcinoma; ccRCC: clear cell renal cell carcinoma; pRCC: papillary renal cell carcinoma; chRCC: chromophobe renal cell carcinoma; RO:
N/A
McCaskill, MD East Lansing, MI 48823 thistinyscar.com Amanda Cooper, PA-C.. Andrea
N/A
ChRCC : chromophobe renal cell carcinoma; nccRCC : non-clear cell renal cell carcinoma; RCC : renal cell carcinoma; TCGA : The Cancer Genome Atlas; WGCNA: weighted gene
N/A
ccRCC – clear cell renal cell carcinoma; chRCC – chromophobe renal cell carcinoma; pRCC – papillary renal cell carcinoma; sRCC – sarcomatoid renal cell carcinoma; cttRCC
N/A
KIRC: kidney renal clear cell carcinoma; RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; TCGA : The Cancer Genome Atlas; GO: gene ontology; KEGG:
N/A
vascular transformation of lymph node sinuses, sarcomatoid renal cell carcinoma, high-grade renal cell carcinoma, clear cell renal cell carcinoma, metastatic renal cell
N/A
RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; mRCC : metastatic renal cell carcinoma; pRCC : papillary renal cell carcinoma; MET: proto-oncogene MET;
N/A
Acquired cystic disease-associated renal cell carcinoma Clear-cell papillary (tubulopapillary) renal cell carcinoma Hereditary leiomyomatosis-associated renal cell carcinoma Renal
N/A
Keywords: fumarate hydratase-deficient renal cell carcinoma, hereditary leiomyomatosis – renal cell carcinoma syndrome, oncocytic carcinoma, renal cell carcinoma,
N/A
b) Lifestyle advice and immediate drug treatment c) Lifestyle advice for 3 months then drug treatment d)Immediate drug treatment.. His BP with ABPM= 150/95... What is your advice?
N/A
BM: Bone metastases; ccRCC: Clear cell renal cell carcinoma; HIF1- α : Hypoxia-inducible factor 1-alpha; mRCC: Metastatic renal cell carcinoma; mTOR: Mammalian target of
N/A
Clear cell carcinoma 70-75% Papillary renal cell carcinoma 10-15% Chromophobe renal cell carcinoma 3-5% Oncocytoma 3-5% Others 1%. Clear cell
N/A
RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; UICC: Inter- national Union Against Cancer; AJCC: American Joint Committee on Cancer; lncRNAs: long noncoding
N/A
KEYWORDS: Chromophobe Renal Cell Carcinoma; Contrast-Enhanced Computed Tomography; Contrast- Enhanced Ultrasound; Histopathology; Papillary Renal Cell Carcinoma; Renal Cell
N/A